Physician profile
Gary A Croll
NPI 1962445916
$1,492.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $209 · 2021: $547 · 2022: $310.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $232.79 | 2019-2022 | |
| Glaxosmithkline, LLC. | $205.01 | 2019-2022 | |
| Amgen INC. | $126.11 | 2019-2021 | |
| Pfizer INC. | $121.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $93.73 | 2019-2021 | |
| Abbott Laboratories | $87.25 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $79.32 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.80 | 2019-2022 | |
| Lilly USA, LLC | $72.82 | 2021-2022 | |
| Amarin Pharma, INC. | $69.52 | 2019-2022 | |
| Abbvie INC. | $62.41 | 2021-2022 | |
| Covis Pharma Gmbh | $47.44 | 2021 | |
| Astellas Pharma US INC | $46.47 | 2020-2021 | |
| Boston Scientific Corporation | $39.94 | 2019 | |
| Merck Sharp & Dohme LLC | $37.09 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.94 | 2021 | |
| Assertio Therapeutics, INC. | $16.31 | 2020 | |
| Dexcom, INC. | $16.01 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.40 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.19 | 2021 | |
| Melinta Therapeutics, LLC | $11.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Croll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.